Aethlon Medical, Inc.

5.75+0.32 (+5.89%)

Oct 29, 4:00:00 PM EDT · NasdaqCM · AEMD · USD

Upcoming Earnings

Report date

≈ Nov 12, 2025 (in 13 days)

Key Stats

Market Cap

4.38M

P/E (TTM)

Basic EPS (TTM)

-66.70

Dividend Yield

Recent Filings

8-K

10/22/25Oct 22, 2025

8-K

10/16/25Oct 16, 2025

8-K

9/12/25Sep 12, 2025

8-K

9/9/25Sep 9, 2025

8-K

8/21/25Aug 21, 2025

About

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

CEO

Mr. James B. Frakes M.B.A.

IPO

3/4/1999

Website

https://www.aethlonmedical.com

Employees

Sector

Healthcare

Industry

Medical Devices